清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Noninvasive detection of perivascular inflammation by coronary computed tomography in the CRISP-CT study and its implications for residual cardiovascular risk

计算机断层摄影术 医学 炎症 心脏病学 残余物 放射科 断层摄影术 内科学 计算机科学 算法
作者
Milind Y. Desai
出处
期刊:Cardiovascular Research [Oxford University Press]
卷期号:115 (1): e3-e4 被引量:5
标识
DOI:10.1093/cvr/cvy282
摘要

Watch the Cardiovascular Research Onlife interview with Professor Charalambos Antoniades, senior author of the CRISP-CT study: https://youtu.be/oBat4xRQH7A. Unstable non-obstructive atherosclerotic plaques account for a significant proportion of acute coronary syndromes, especially when they get inflamed. Unfortunately, most of such plaques cannot be identified on non-invasive testing which rely on detection of flow-limiting stenosis.1–3 While certain inflammatory biomarkers like C-reactive protein increase risk of a major cardiovascular event,4,5 they are considered relatively non-specific to precisely detect actual inflammatory activity at the level of an individual coronary artery. In recent years, there is an increased understanding that the adipose tissue adjacent to the coronary arteries and the heart is an active area, generating many inflammatory agents within the local milieu. This is suspected of promoting progression of atherosclerotic changes within the coronary arteries, with resultant major adverse cardiac events. Coronary computed tomography angiography (CTA) is an established and highly sensitive non-invasive technique to detect obstructive and non-obstructive coronary artery disease (CAD).6 However, it has not been well-studied as a technique to detect inflammatory changes (or its impact on future coronary events) in the surrounding fatty tissue. Recently, a new index, fat attenuation index (FAI), has been developed to detect and quantify changes in perivascular fat resulting from ongoing inflammation, using clinically acquired coronary CTA.7 It appears that the inflamed coronary arteries release signals into the surrounding adipose tissue, which results in inhibition of local adipogenesis. This ultimately alters perivascular fat composition adjacent to the inflamed coronaries and shifts the attenuation on coronary CTA from the lipid to the aqueous phase. Perivascular FAI captures these inflammation-induced changes on routine coronary CTA, resulting in earlier detection of coronary inflammation. However, the index’s utility for clinical risk stratification was uncertain, prompting the CRISP-CT study, which tests the association between FAI and future fatal myocardial infarctions.8 To test this hypothesis in patients with suspected CAD, we collected data from the two cohorts of consecutive patients undergoing standard coronary CTA: 1872 patients in Germany from 2005 to 2009 (derivation cohort) and 2040 patients at Cleveland Clinic from 2008 to 2016 (validation cohort). The median ages were 62 years and 53 years, respectively. Perivascular FAI was measured around the three large epicardial coronary arteries—proximal right, left anterior descending, and left circumflex. Subsequently, the incremental prognostic utility of perivascular FAI was studied for all-cause and cardiac mortality upto a median of 72 months (range 51–109) in the derivation cohort and 54 months (range 4–105) in the validation cohort. Perivascular FAI values around the proximal right coronary artery and left anterior descending artery were predictive of all-cause and cardiac mortality in both cohorts. We subsequently used the perivascular FAI value around the right coronary artery as a marker of coronary inflammation [hazard ratio (HR) for cardiac mortality of 2.15 [95% confidence interval (CI) 1.33–3.48] in the derivation cohort and 2.06 (95% CI 1.50–2.83) in the validation cohort]. The study also demonstrated that the optimal perivascular FAI cut-off in the derivation cohort was −70.1 Hounsfield units or higher [HR = 9.04 (95% CI 3.35–24.40) for cardiac mortality and HR = 2.55 (95% CI 1.65–3.92) for all-cause mortality]. This cut-off value was confirmed in the validation cohort [HR = 5.62 (95% CI 2.90–10.88) for cardiac mortality and HR = 3.69 (95% CI 2.26–6.02) for all-cause mortality]. Perivascular FAI significantly improved risk stratification in both cohorts beyond current risk models. These findings could be of potential significance because almost 50% of the myocardial infarctions occur in the absence of substantial coronary stenosis.1 The CRISP-CT study also highlights the importance of diligent translational research which resulted in the development of an imaging biomarker in a basic science realm, with subsequent application, and validation in a large human cohort across continents.7,8 The perivascular FAI potentially identifies higher-risk patients who may have highly inflamed and potentially unstable atherosclerotic plaques. Routine coronary CT angiography could help potentially identify the residual inflammatory risk that is captured by the perivascular FAI. These are patients who might not get recognized early and the use of this new biomarker could potentially help institute intensive preventative strategies. Future studies in this field should encompass the basic and clinical science arena. In the basic arena, FAI could be used to test for personalized triggers of inflammation (either environmental or genetic). In addition, it can be utilized to detect improvements in the local inflammatory milieu following development of novel anti-inflammatory therapies. From a broadly relevant clinical perspective, FAI can be targeted to intensify existing therapies or developing newer therapies (which in turn could further attenuate risk of future coronary events) could be tested as part of well-designed prospective randomized studies. Such studies could prove conclusively whether FAI could serve as a marker of personalized medicine in this secondary prevention setting. Also, an important next step would be to operationalize this marker for routine clinical use. M.Y.D. is the recipient of the Haslam family endowed chair in Cardiovascular Medicine and acknowledges the Khouri family for their support of research in early detection of coronary artery disease. Biography: Milind Desai, MD, is Cardiologist in the Robert and Suzanne Tomsich, Department of Cardiovascular Medicine at the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He holds the Haslam Family endowed chair in CV medicine. He is a Professor of Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He holds dual appointments in the Departments of Cardiovascular Medicine and Radiology.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
桐桐的应助被西红柿采纳,获得10
刚刚
2秒前
Qian完成签到 ,获得积分10
2秒前
动听一德完成签到,获得积分10
8秒前
8秒前
无语的羞花完成签到,获得积分10
9秒前
17秒前
18秒前
纯情的阁发布了新的文献求助10
19秒前
19秒前
纯情的阁发布了新的文献求助30
21秒前
纯情的阁发布了新的文献求助10
25秒前
25秒前
纯情的阁发布了新的文献求助10
27秒前
27秒前
缥缈的鸡翅完成签到,获得积分10
30秒前
科研通AI6.4的应助被纯情的阁采纳,获得10
35秒前
35秒前
故意的冷安完成签到,获得积分10
37秒前
42秒前
坚定的咖啡完成签到,获得积分10
42秒前
冷艳千柳完成签到,获得积分10
42秒前
45秒前
1分钟前
1分钟前
科研通AI6.4的应助被纯情的阁采纳,获得10
1分钟前
科研通AI6.4的应助被纯情的阁采纳,获得30
1分钟前
科研通AI6.2的应助被纯情的阁采纳,获得10
1分钟前
池雨完成签到 ,获得积分10
1分钟前
苗条的香萱完成签到,获得积分10
1分钟前
年轻狗完成签到,获得积分10
1分钟前
1分钟前
1分钟前
研友_nqrKQZ发布了新的文献求助10
1分钟前
隐形曼青的应助被研友_nqrKQZ采纳,获得10
1分钟前
1分钟前
爱听歌的语堂完成签到,获得积分10
1分钟前
1分钟前
1分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158905
求助须知:如何正确求助?哪些是违规求助? 9554522
关于积分的说明 21719373
捐赠科研通 7748459
什么是DOI,文献DOI怎么找? 3427107
关于科研通互助平台的介绍 2552006
邀请新用户注册赠送积分活动 2471370